Metabolic
GLP-3 RT + Cagri 10-Pack
Ten vials, one case - Ten GLP-3 RT + Cagri vials in one case, at the ten-vial price.
Ten vials of GLP-3 RT + Cagri in one protective case, at the ten-vial price (60% off the single-vial list price). Same lots and certificates as our single vials. Buy 1 Get 1, promo codes and payment discounts do not apply to 10-packs.
GLP-3 RT + Cagri 10-Pack specifications
- Sequence
- GLP-3 RT 10mg + Cagrilintide 2mg
- Presentation
- Lyophilized powder
- Documented purity
- 99.87% by HPLC
- Available sizes
- 10mg / 2mg ($360)
- Intended use
- Laboratory research use only. Not for human or veterinary use.
Studied pathways
- Incretin-receptor engagement - The GLP-3 RT component is studied across the GLP-1, GIP and glucagon receptor families in in-vitro assays.
- Amylin-receptor engagement - The Cagrilintide component is characterized at amylin and calcitonin receptors.
Published literature on GLP-3 RT + Cagri 10-Pack
The mechanisms above trace to peer-reviewed studies indexed on PubMed. These are independent third-party publications, not Aspect Peptides claims. Browse indexed research on PubMed.
Documented to 99.87% purity by HPLC · third-party COA every lot · from $360 · For laboratory research use only.
Related Metabolic compounds
- GLP-1 S - Single-agonist GLP-1 research compound.
- GLP-3 RT - Triple-receptor GLP research compound (GLP-1/GIP/glucagon class).
- GLP-2 TZ - Dual GIP/GLP-1 receptor co-agonist studied in glucose-handling and energy-balance research.
- Cagrilintide - Acylated amylin analogue studied for amylin and calcitonin receptor signaling.
- GLP-3 RT + Cagri - GLP-3 RT (10mg) co-formulated with Cagrilintide (2mg) in one vial.
- 5-Amino-1MQ - Small-molecule NNMT inhibitor studied in metabolism research.